IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación (Site 1052)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Prostate cancer

Running trials

• Recruiting

  A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  NCT06136650· Phase 3· Merck Sharp & Dohme LLC· Source

  Contact: Study Coordinator

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Prostate cancer1 recruiting